<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim was to study the effectiveness of prescription medication containing 90% omega-3 polyunsaturated fatty acids for 6 months on <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> in patients with <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> less than a year ago </plain></SENT>
<SENT sid="1" pm="."><plain>The study involved 56 patients with <z:hpo ids='HP_0006682'>ventricular extrasystoles</z:hpo>, from 500 to 1000 per day </plain></SENT>
<SENT sid="2" pm="."><plain>Divided into two groups of patients we divided into I group - 30 people - received in addition to standard drug therapy of omega-3 PUFA 1 g daily, for 6 months; II group - 26 men were given only previously assigned therapies </plain></SENT>
<SENT sid="3" pm="."><plain>The average age of patients in group I - 60,7+/-8,6, II group - 61+/-9,7 years (p&gt; 0,05) </plain></SENT>
<SENT sid="4" pm="."><plain>ECG monitoring was performed at 3 and 6 months </plain></SENT>
<SENT sid="5" pm="."><plain>Administration of highly concentration preparation of omega-3 PUFAs for 3 months reduced number of <z:mp ids='MP_0010018'>PVCs</z:mp> per day, frequencies of grades 2, 3, 4A, 4B, and high grade <z:mp ids='MP_0010018'>PVCs</z:mp> (grades 3 - 5) as a whole </plain></SENT>
<SENT sid="6" pm="."><plain>These effects persisted after 6 months of treatment </plain></SENT>
</text></document>